Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Senhwa Biosciences Reports Positive Phase 1 Data of CX-5461 in Patients With Advanced Solid Tumors at 2019 SABCS

prnasiaDecember 16, 2019

Tag: Senhwa Biosciences Inc. , Positive Phase 1 Data , CX-5461

PharmaSources Customer Service